000950 On Other Exchanges
Symbol
Exchange
Shenzhen

chongqing jianfeng chemi-a (000950) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHONGQING JIANFENG CHEMI-A (000950)
\

Related News

No related news articles were found.

chongqing jianfeng chemi-a (000950) Related Businessweek News

No Related Businessweek News Found

chongqing jianfeng chemi-a (000950) Details

C.Q. Pharmaceutical Holding Co., Ltd. distributes pharmaceutical products. Chongqing Medicines Co., Ltd. was formerly known as Southwest Branch of China Medicine Company. The company was founded in 1950 and is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. develops, manufactures, and distributes pharmaceuticals. The company is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. operates as a subsidiary of Chongqing Chemical & Pharmaceutical Holding Group Company

7,806 Employees
Last Reported Date: 04/22/19
Founded in 1950

chongqing jianfeng chemi-a (000950) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

chongqing jianfeng chemi-a
C.Q. Pharmaceutical's Controlling Shareholder To Transfer 38.5% Stake

C.Q. Pharmaceutical Holding Co., Ltd. (SZSE:000950) said controlling shareholder plans to transfer 38.5% stake in the company to boost healthcare unit's capital.

C.Q. Pharmaceutical Holding Co., Ltd., Special/Extraordinary Shareholders Meeting, May 27, 2019

C.Q. Pharmaceutical Holding Co., Ltd., Special/Extraordinary Shareholders Meeting, May 27, 2019, at 14:30 China Standard Time. Agenda: To discuss issuance of debt financing products by the Company and controlled subsidiaries; and to discuss launching accounts receivable asset-backed securities or notes and launching accounts receivable non-recourse factoring business by controlled subsidiaries.

C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019

C.Q. Pharmaceutical Holding Co., Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was CNY 7,909.446 million compared to CNY 6,070.791 million a year ago. Operating income was CNY 181.556 million compared to CNY 158.435 million a year ago. Net income was CNY 131.507 million compared to CNY 137.390 million a year ago. Basic earnings per share from continuing operations was CNY 0.08 compared to CNY 0.08 a year ago.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

000950 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 000950.
View Industry Companies
 

Industry Analysis

000950

Industry Average

Valuation 000950 Industry Range
Price/Earnings 13.7x
Price/Sales 0.3x
Price/Book 1.3x
Price/Cash Flow 13.9x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHONGQING JIANFENG CHEMI-A, please visit www.cqphar.com/cqp/. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.